Literature DB >> 27824512

Hypoxia: A Double-Edged Sword in Cancer Therapy.

Hamed Manoochehri Khoshinani1, Saeid Afshar1, Rezvan Najafi1.   

Abstract

Hypoxia is a common feature of malignant tumors. There is an interactive connection between hypoxia and chemoresistance, radioresistance, invasiveness, and angiogenesis. Therefore, tumor hypoxia has been considered as a validated target for treating cancer. This review focuses on the role of hypoxia on chemoresistance and radioresistance. In addition, we address several approaches targeting tumor hypoxia, known as hypoxia-targeted therapy.

Entities:  

Keywords:  Chemoresistance; HIF-1; Hypoxia; Hypoxia-targeted therapy; Radioresistance

Mesh:

Substances:

Year:  2016        PMID: 27824512     DOI: 10.1080/07357907.2016.1245317

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  50 in total

Review 1.  Role of hyperoxic treatment in cancer.

Authors:  Sei W Kim; In K Kim; Sang H Lee
Journal:  Exp Biol Med (Maywood)       Date:  2020-04-23

Review 2.  Exercise as Adjunct Therapy in Cancer.

Authors:  Kathleen A Ashcraft; Allison Betof Warner; Lee W Jones; Mark W Dewhirst
Journal:  Semin Radiat Oncol       Date:  2019-01       Impact factor: 5.934

3.  HIF-1-dependent heme synthesis promotes gemcitabine resistance in human non-small cell lung cancers via enhanced ABCB6 expression.

Authors:  Lisha Xiang; Yongsheng Wang; Jie Lan; Feifei Na; Shuang Wu; Yuzhu Gong; Hanjian Du; Bin Shao; Ganfeng Xie
Journal:  Cell Mol Life Sci       Date:  2022-06-04       Impact factor: 9.261

4.  Identification of Key Gene Targets for Sensitizing Colorectal Cancer to Chemoradiation: an Integrative Network Analysis on Multiple Transcriptomics Data.

Authors:  Hamed Manoochehri; Akram Jalali; Hamid Tanzadehpanah; Amir Taherkhani; Massoud Saidijam
Journal:  J Gastrointest Cancer       Date:  2021-08-25

5.  Exploring the underlying molecular mechanism of liver cancer cells under hypoxia based on RNA sequencing.

Authors:  Xin Zhao; Wenpeng Liu; Baowang Liu; Qiang Zeng; Ziqiang Cui; Yang Wang; Jinglin Cao; Qingjun Gao; Caiyan Zhao; Jian Dou
Journal:  BMC Genom Data       Date:  2022-05-19

6.  LINCS gene expression signature analysis revealed bosutinib as a radiosensitizer of breast cancer cells by targeting eIF4G1.

Authors:  Sai Hu; Dafei Xie; Pingkun Zhou; Xiaodan Liu; Xiaoyao Yin; Bo Huang; Hua Guan
Journal:  Int J Mol Med       Date:  2021-03-11       Impact factor: 4.101

7.  Chitosan oligosaccharide decorated liposomes combined with TH302 for photodynamic therapy in triple negative breast cancer.

Authors:  Yinan Ding; Rui Yang; Weiping Yu; Chunmei Hu; Zhiyuan Zhang; Dongfang Liu; Yanli An; Xihui Wang; Chen He; Peidang Liu; Qiusha Tang; Daozhen Chen
Journal:  J Nanobiotechnology       Date:  2021-05-19       Impact factor: 10.435

8.  β-Patchoulene represses hypoxia-induced proliferation and epithelial-mesenchymal transition of liver cancer cells.

Authors:  Huahua Tu; Wei Wang; Yanqing Feng; Linfei Zhang; Huadong Zhou; Caitao Cheng; Lei Ji; Qinghe Cai; Yong Feng
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

Review 9.  Hypoxia Signaling in Cancer: From Basics to Clinical Practice.

Authors:  Anna Sebestyén; László Kopper; Titanilla Dankó; József Tímár
Journal:  Pathol Oncol Res       Date:  2021-05-03       Impact factor: 3.201

10.  Hypoxia stimulates the migration and invasion of osteosarcoma via up-regulating the NUSAP1 expression.

Authors:  Ling Zhang; Jingtao Song; Xu Xin; Donghong Sun; Huiting Huang; Yang Chen; Tao Zhang; Yiming Zhang
Journal:  Open Med (Wars)       Date:  2021-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.